title: [Complex dietary measures and pharmacotherapy for metabolic syndrome].
abstract: Metabolic syndrome is characterized by a group of risk factors (obesity, glucose metabolism disorders, dyslipidemia and hypertension) which appear to be caused by obesity related mechanisms of cellular metabolism and the systemic energy balance. A fibre poor diet rich in fat combined with lack of physical activity are important causative factors. A suitable change in diet combined with regular physical exercise and a moderate weight loss of about 5% leads to a massive reduction in the consequential disease diabetes type 2 by 60% in pre-diabetics and reduces the risk factors for metabolic syndrome. Pharmacological therapies using metformin or acarbose were about half as effective in reducing new cases of diabetes, while thiazolidinedione also led to a 60% reduction in new diabetes cases in pre-diabetics in spite of a weight increase. A sensible and realizable change in lifestyle provides a highly efficient therapy of metabolic syndrome, in addition to effective pharmacological options.
authors.affiliation: Abt. Klinische Ernährung, Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Deutschland. afhp@dife.de
authors.forename: A F H
authors.initials: AF
authors.lastname: Pfeiffer
authors.forename: A
authors.initials: A
authors.lastname: Kohl
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology* / Q000628:therapy*; D004035:Diet Therapy / Q000379:methods*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000453:epidemiology* / Q000628:therapy*; D009765:Obesity / Q000453:epidemiology / Q000517:prevention & control; D026741:Physical Therapy Modalities; D040242:Risk Reduction Behavior
chemical_list: D007004:Hypoglycemic Agents